Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose calcitriol to modulate T-helper immune polarization in healthy women
NL-OMON29360Active, not recruiting
- Sponsor
- Amsterdam UMC
- Start
- Nov 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of calcitriol in autoimmune disease (2 arms), sponsored by Amsterdam UMC. Primary endpoints: Interferon gamma production, Serum 1,25-dihydroxyvitamin D3 level and 1 more. Started Nov 2006; status: active, not recruiting.
02
Drugs
calcitriol
03
Conditions
autoimmune disease
Beyond the preview
Go deeper on NL-OMON29360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29360.